BBM-P002

· Shanghai Xinzhi BioMed Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BBM-P002, covering 2026-01-15 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease [Phase 1]

See pricing